Concepedia

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung, Susanna S. Ng, Kaimin Chan, Fanny W.S. Ko, Chunke Chen, Karen Yiu, Bosco HS Lam, Eric H. Y. Lau,

Nature Medicine · 2022 · 374 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury, Deborah Cromer, Arnold Reynaldi et al. · Nature Medicine · 2021 · 4.2K citations · Full text

, , +16

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

New England Journal of Medicine · 2021 · 1.8K citations · Full text

, , +17

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Shutoku Matsuyama, Naganori Nao, Kazuya Shirato et al. · Proceedings of the National Academy of Sciences · 2020 · 1.6K citations · Full text

, , +17

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

, , +17

Correlates of protection against SARS-CoV-2 in rhesus macaques

Katherine McMahan, Jingyou Yu, Noe B. Mercado et al. · Nature · 2020 · 1.2K citations · Full text

, , +12